Back to the future: the evolution of clinical conference topics in the past decade
With the 20th birthday of the renowned Clinical Trial Supply East Coast conference in October, we look at topic changes in the past decade.
By
Reynald Castañeda
Reynald Castañeda is the lead editor of Clinical Trials Arena. Reynald's coverage focuses on outsourcing, partnering, and supply chains. An experienced healthcare journalist, he was previously an associate editor for GlobalData’s Investigative News Team, writing scoops and feature news articles on drug development.
Latest articles
All Articles
Overcoming obstacles in trans and nonbinary participation in clinical trials
The clinical trials sector can make small changes to make transgender, nonbinary individuals feel safe to join studies.
By
Should rheumatoid arthritis trials exclude patients based on their Covid-19 vaccine status?
There are 166 rheumatoid arthritis studies in the planning stage, with four ongoing or planned trials with criteria specifically…
By
Beyond clinical trial design: factors that impact decentralisation
DCT Adoption Tracker: Clear regulatory guidance, existing healthcare infrastructure, and local culture are key influencers for swift decentralisation uptake.
By
ASCO rectal cancer trial result draw publicity but what is the impact?
Data from a Phase II rectal cancer trial was in the limelight at this year’s ASCO meeting but the…
By
Just-in-time: on schedule to rescue the clinical trial supply chain?
Just-in-time has clear implementation pluses in clinical trials, especially amidst global supply chain issues. But uptake is yet to…
By
Increased initiatives to up Indigenous Australian clinical trials yet to move the needle
Some 9,206 clinical trials were included in the analysis, with 139 focusing on Indigenous health. There is no relative…
By
The great wall: why overseas sponsors are yet to fully tap into China’s clinical trial resources
China is an attractive study destination, yet our data-driven analysis shows the country’s clinical trial industry is still insular.…
By
DCT tech language divide: risking clinical trial data integrity
With the rise of tech aiding DCT, developers point to challenges in safeguarding seamless communication between products.
By